Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

New Day, New Test of the Great S&P 500 Bull Run

Egged on by the horrendous retail sales data, S&P 500 intraday decline has gathered steam yesterday. An 8.7% drop in consumer spending can’t be just waved off. Neither can the Empire State Manufacturing Index at -78.2. We have the impression that the world is w...
Monica Kingsley | April 16, 2020 |

Bitcoin - Breakout In Progress

After a great start into 2020 bitcoin crashed together with all other markets during the corona panic. Now bitcoin has full recovered from these dark moments in mid of march and has just yesterday crossed the US$10,000 level once again. While central bankers around the world a...
Florian Grummes | May 9, 2020 |

S&P 500 in the Aftermath of Fed’s $2.3T Backstop

Let’s join yesterday’s Gold & Silver Weekend Special, and bring you an advance one in stocks as well. As the coronavirus crisis, response and anticipations are what is moving the markets, today’s Alert will draw on yesterday&Cl...
Monica Kingsley | April 13, 2020 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

B2Gold, Newmont, Osino Resources - Inflation will fuel gold demand

Something is going wrong in the economic system. You don't need to study to get this impression, a glance at the daily press or social media is enough. The past decade is celebrated by politicians as an economic success because, among other things, there was no recession in Ge...
Mario Hose | January 17, 2020 |

Site visit: Building PGE-nickel-copper riches at the Stillwater West project, Montana

Initially published in Resource Opportunities. Subscribe now: use coupon code CEO to save US$100 on regular subscription prices of US$299 for 1 year or $449 for 2 years. ResourceOpportunities.com/subscription-information/ Assays are pending for holes drilled th...
James Kwantes | December 4, 2019 |

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...
Streetwise Reports | January 6, 2020 |

Barrick Gold, B2Gold, Newmont - who buys which gold explorer?

The price of the troy ounce of gold is at its highest level in seven years. Currently, the precious metal costs around USD 1,650.00. The value of the troy ounce has thus increased by more than 30% in the past 12 months from under USD 1,270.00. Because the precious metal is con...
Mario Hose | February 25, 2020 |

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. ...
Streetwise Reports | April 28, 2020 |

Getchell Won't Force Warrants

I wrote about an interesting young company back in February before all the Corona Virus issue. Someone was talking to me recently and the issue of warrants in the company came up. You should read what I had to say about Getchell Gold Corp. (GTCH:CSE) three months ago....
Streetwise Reports | April 29, 2020 |
1 2 3 4 5 6 7 8 9 10 ...